A Guideline for Assessment and Characterization of Bacterial Biofilm Formation in the Presence of Inhibitory Compounds.

Bassam A Elgamoudi, Victoria Korolik
Author Information
  1. Bassam A Elgamoudi: Institute for Glycomics, Griffith University, Gold Coast, QLD, Australia.
  2. Victoria Korolik: Institute for Glycomics, Griffith University, Gold Coast, QLD, Australia.

Abstract

jejuni, a zoonotic foodborne pathogen, is the worldwide leading cause of acute human bacterial gastroenteritis. Biofilms are a significant reservoir for survival and transmission of this pathogen, contributing to its overall antimicrobial resistance. Natural compounds such as essential oils, phytochemicals, polyphenolic extracts, and D-amino acids have been shown to have the potential to control biofilms formed by bacteria, including spp. This work presents a proposed guideline for assessing and characterizing bacterial biofilm formation in the presence of naturally occurring inhibitory molecules using as a model. The following protocols describe: i) biofilm formation inhibition assay, designed to assess the ability of naturally occurring molecules to inhibit the formation of biofilms; ii) biofilm dispersal assay, to assess the ability of naturally occurring inhibitory molecules to eradicate established biofilms; iii) confocal laser scanning microscopy (CLSM), to evaluate bacterial viability in biofilms after treatment with naturally occurring inhibitory molecules and to study the structured appearance (or architecture) of biofilm before and after treatment.

Keywords

References

  1. Int J Food Microbiol. 2017 Jul 17;253:20-28 [PMID: 28463724]
  2. Poult Sci. 2009 May;88(5):1102-7 [PMID: 19359701]
  3. J Microbiol Methods. 2008 Feb;72(2):157-65 [PMID: 18155789]
  4. Foods. 2020 Jun 16;9(6): [PMID: 32560249]
  5. PLoS One. 2019 Apr 10;14(4):e0215275 [PMID: 30970009]
  6. Can J Microbiol. 2021 Apr;67(4):301-309 [PMID: 33703923]
  7. Int J Mol Sci. 2021 Nov 10;22(22): [PMID: 34830039]
  8. Microorganisms. 2022 Oct 14;10(10): [PMID: 36296307]
  9. J Microbiol Methods. 2013 Oct;95(1):39-47 [PMID: 23810971]
  10. Front Microbiol. 2020 Oct 29;11:566325 [PMID: 33193155]
  11. NPJ Biofilms Microbiomes. 2021 May 14;7(1):44 [PMID: 33990612]
  12. Biofilm. 2019 Nov 19;2:100010 [PMID: 33447797]
  13. Can J Public Health. 1990 Jul-Aug;81(4):268-71 [PMID: 2207948]
  14. Microbiology (Reading). 2016 Sep;162(9):1708-1714 [PMID: 27460095]
  15. Appl Environ Microbiol. 2010 Apr;76(7):2122-8 [PMID: 20139307]
  16. Appl Environ Microbiol. 2012 Feb;78(4):1033-8 [PMID: 22179238]
  17. Bull Exp Biol Med. 2019 Apr;166(6):759-765 [PMID: 31028588]
  18. J Infect Dis. 1997 Dec;176 Suppl 2:S192-7 [PMID: 9396710]
  19. Antibiotics (Basel). 2020 Nov 23;9(11): [PMID: 33238583]
  20. BMC Microbiol. 2012 Jun 29;12:128 [PMID: 22747654]
  21. J Appl Microbiol. 2008 Oct;105(4):1199-208 [PMID: 18557961]
  22. RSC Adv. 2019 Jan 29;9(7):3938-3945 [PMID: 35518066]
  23. Front Microbiol. 2020 Jan 10;10:2920 [PMID: 31998253]
  24. Front Cell Infect Microbiol. 2021 Feb 04;10:596570 [PMID: 33614524]
  25. Microb Cell. 2021 Feb 01;8(2):28-56 [PMID: 33553418]

Word Cloud

Created with Highcharts 10.0.0biofilmsbiofilmnaturallyoccurringmoleculesassayBiofilmbacterialcompoundsformationinhibitorypathogenNaturalD-aminoacidsassessabilitytreatmentjejunizoonoticfoodborneworldwideleadingcauseacutehumangastroenteritisBiofilmssignificantreservoirsurvivaltransmissioncontributingoverallantimicrobialresistanceessentialoilsphytochemicalspolyphenolicextractsshownpotentialcontrolformedbacteriaincludingsppworkpresentsproposedguidelineassessingcharacterizingpresenceusingmodelfollowingprotocolsdescribe:inhibitiondesignedinhibitiidispersaleradicateestablishediiiconfocallaserscanningmicroscopyCLSMevaluateviabilitystudystructuredappearancearchitectureGuidelineAssessmentCharacterizationBacterialFormationPresenceInhibitoryCompoundsAntibiofilmmethodCampylobacterMicrotiterplate

Similar Articles

Cited By